The uncertainties looming over Brexit have caused worries on the global economy and also the continuity of quality healthcare services. However, much less has been discussed on the implications of this momentous decision in the Asia Pacific, especially regulatory authorities which reference the health product decisions made in the EU and UK. Hear from two experts who are deeply involved on this matter, sharing on the potential effects of Brexit on access to health products, how this may influence activities in this region, and what can be done to better prepare our systems against the impact.